Although the precise molecular etiology of SMA remains unclear, overwhelming evidence shows that reduced SMN protein levels cause the disease (Ahmad et al., 2016; Briese et al., 2005; Chaytow et al., 2018; Deguise and Kothary, 2017; Li et al., 2014). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.